Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
ArcBest
ARCB
$3.14B
| $30.9M | 0.01% |
377,919
+12,707
| +3% | +$838K |
|
|
AZEK
1202
DELISTED
The AZEK Co
AZEK
| $30.9M | 0.01% |
845,843
-193,571
| -19% | -$7.54M |
|
1203
Advanced Energy
AEIS
$13.5B
| $30.9M | 0.01% |
351,713
+3,609
| +1% | +$338K |
|
1204
Berkshire Hathaway Class A
BRK.A
$1.09T
| $30.9M | 0.01% |
75
+3
| +4% | +$1.27M |
|
1205
NorthWestern Energy
NWE
$4.34B
| $30.8M | 0.01% |
538,102
+25,321
| +5% | +$1.57M |
|
1206
Howard Hughes
HHH
$3.98B
| $30.8M | 0.01% |
368,337
-23,708
| -6% | -$2.05M |
|
|
DOOR
1207
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $30.8M | 0.01% |
289,737
-8,944
| -3% | -$1.02M |
|
|
EVBG
1208
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $30.7M | 0.01% |
203,047
+4,730
| +2% | +$700K |
|
1209
ACI Worldwide
ACIW
$5.33B
| $30.5M | 0.01% |
993,762
+22,785
| +2% | +$756K |
|
1210
Amkor Technology
AMKR
$13.8B
| $30.5M | 0.01% |
1,223,387
-73,107
| -6% | -$1.86M |
|
1211
Haemonetics
HAE
$4.16B
| $30.5M | 0.01% |
432,216
+10,861
| +3% | +$685K |
|
1212
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
| $30.5M | 0.01% |
922,713
-32,418
| -3% | -$1.07M |
|
1213
Walker & Dunlop
WD
$1.45B
| $30.5M | 0.01% |
268,387
-445
| -0.2% | -$46.6K |
|
1214
Interactive Brokers
IBKR
$41.5B
| $30.4M | 0.01% |
1,953,388
+197,536
| +11% | +$3.11M |
|
1215
TG Therapeutics
TGTX
$7.58B
| $30.4M | 0.01% |
914,467
+45,885
| +5% | +$1.42M |
|
1216
Vir Biotechnology
VIR
$1.52B
| $30.4M | 0.01% |
698,644
+110,188
| +19% | +$4.77M |
|
1217
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $30.3M | 0.01% |
724,968
+23,976
| +3% | +$1.04M |
|
1218
Southwest Gas
SWX
$6.68B
| $30.3M | 0.01% |
453,387
-112,203
| -20% | -$7.83M |
|
1219
Community Bank
CBU
$3.43B
| $30.2M | 0.01% |
441,850
+8,961
| +2% | +$643K |
|
1220
Brinker International
EAT
$10.5B
| $30.2M | 0.01% |
614,800
+8,929
| +1% | +$486K |
|
|
NEWR
1221
DELISTED
New Relic, Inc.
NEWR
| $30.1M | 0.01% |
419,769
+12,809
| +3% | +$946K |
|
|
SPR
1222
DELISTED
Spirit AeroSystems
SPR
| $30.1M | 0.01% |
680,457
-16,029
| -2% | -$671K |
|
1223
Ollie's Bargain Outlet
OLLI
$4.73B
| $30M | 0.01% |
498,431
+28,759
| +6% | +$2.33M |
|
1224
Schwab US Dividend Equity ETF
SCHD
$107B
| $30M | 0.01% |
1,214,019
+38,967
| +3% | +$990K |
|
|
MDLA
1225
DELISTED
Medallia, Inc.
MDLA
| $30M | 0.01% |
886,848
+243,204
| +38% | +$8.12M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.